Fjarde Ap-fonden’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-27,000
| Closed | -$2.01M | – | 573 |
|
2021
Q1 | $2.01M | Buy |
27,000
+600
| +2% | +$44.7K | 0.02% | 550 |
|
2020
Q4 | $4.5M | Buy |
26,400
+400
| +2% | +$68.2K | 0.04% | 411 |
|
2020
Q3 | $3.65M | Buy |
26,000
+2,300
| +10% | +$323K | 0.04% | 433 |
|
2020
Q2 | $3.8M | Sell |
23,700
-2,500
| -10% | -$401K | 0.05% | 384 |
|
2020
Q1 | $2.56M | Buy |
26,200
+600
| +2% | +$58.7K | 0.04% | 428 |
|
2019
Q4 | $3.3M | Buy |
25,600
+3,000
| +13% | +$387K | 0.04% | 465 |
|
2019
Q3 | $1.7M | Buy |
+22,600
| New | +$1.7M | 0.02% | 548 |
|